Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products

Liam Simms, Fan Yu, Jessica Palmer, Kathryn Rudd, Edgar Trelles Sticken, Roman Wieczorek, Fiona Chapman, Lukasz Czekala, Matthew Stevenson, Grant O’Connell

Open source

DOI: 10.3389/ftox.2022.747508
Published: 2022-02-16
Container: Frontiers in Toxicology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/ftox.2022.747508,
  title = {Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products},
  author = {Liam Simms and Fan Yu and Jessica Palmer and Kathryn Rudd and Edgar Trelles Sticken and Roman Wieczorek and Fiona Chapman and Lukasz Czekala and Matthew Stevenson and Grant O’Connell},
  year = {2022},
  journal = {Frontiers in Toxicology},
  doi = {10.3389/ftox.2022.747508},
  url = {https://doi.org/10.3389/ftox.2022.747508}
}

RIS

TY  - JOUR
TI  - Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products
AU  - Liam Simms
AU  - Fan Yu
AU  - Jessica Palmer
AU  - Kathryn Rudd
AU  - Edgar Trelles Sticken
AU  - Roman Wieczorek
AU  - Fiona Chapman
AU  - Lukasz Czekala
AU  - Matthew Stevenson
AU  - Grant O’Connell
PY  - 2022
JO  - Frontiers in Toxicology
DO  - 10.3389/ftox.2022.747508
UR  - https://doi.org/10.3389/ftox.2022.747508
ER  -

APA

Simms, L., Yu, F., Palmer, J., Rudd, K., Sticken, E. T., Wieczorek, R., Chapman, F., Czekala, L., Stevenson, M., & O’Connell, G. (2022). Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products. Frontiers in Toxicology. https://doi.org/10.3389/ftox.2022.747508

Source records

crossref · retrieved 2026-09-27T01:03:41.591Z